Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 371-380 of 416 for multiple

Edit search filters
  1. A Dose Escalation Study of BLU-5937 in Unexplained or Refractory Chronic Cough

    Rochester, MN

  2. Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors

  3. A Phase 1, Randomized, Double-blind, Placebo-controlled Study Evaluating AMG 691 In Healthy Participants And Participants With Mild-to-Moderate Asthma

    Rochester, MN

  4. A Phase 1/2 Study To Investigate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, And Efficacy Of HMB-001 In Glanzmann Thrombasthenia

    Rochester, MN

  5. A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of NIO752 in Participants with Progressive Supranuclear Palsy

    Rochester, MN

  6. A Study of the Safety and Drug/Body Interactions of BGB-3111 for Patients with B-Cell Lymphoid Malignancies

    Rochester, MN

  7. Impact of Restricted Medication Access on Care of Multiple Myeloma Patients

    Rochester, MN

  8. Evaluation of a Clinical Tool to Assess Patient Treatment Experience and Self-Management (PETS-Now)

    Rochester, MN

  9. The Validation of the CAP-PRI (Chronic Acquired Polyneuropathy-Patient Reported Index) in Patients with Acquired and Idiopathic Polyneuropathy

    Rochester, MN

  10. A Study of Crenezumab in Participants With Mild to Moderate Alzheimer Disease

    Scottsdale/Phoenix, AZ

.

Mayo Clinic Footer